Introduction to Planova FG1 by Asahi Kasei Medical
Asahi Kasei Medical has introduced the Planova™ FG1, a next-generation virus removal filter aimed at revolutionizing the production of biotherapeutics. This innovative filter, launched to meet the increasing demand for efficient manufacturing processes, boasts a significantly higher flux capability, making it a pivotal tool for biopharmaceutical advancements.
The Growth of Bioprocess Technologies
Asahi Kasei Medical's bioprocess division specializes in virus removal technologies and equipment essential for producing biotherapeutic products, which encompass biopharmaceuticals and plasma derivatives. Their presence in the industry reflects Asahi Kasei Group's commitment to driving growth through innovation and advanced solutions.
History and Evolution of Planova Filters
Since its inception in 1989, the Planova product line has undergone significant enhancements. Notable expansions include the 2009 introduction of Planova™ BioEX hydrophilic PVDF hollow-fiber membrane filters and the 2022 launch of Planova™ S20N cellulose hollow-fiber membrane filters. This evolution has set new benchmarks for viral safety, addressing stringent global standards.
Enhanced Features of Planova FG1
The Planova™ FG1 filter stands out due to its exceptional productivity features, particularly in the realm of biopharmaceutical manufacturing. It offers a filtration speed that is seven times faster than its predecessor, Planova™ BioEX, effectively shortening the time required for virus filtration processes. Furthermore, its design minimizes the risk of virus breakthrough during filtration suspensions, ensuring robust performance.
Catering to Biopharmaceutical Manufacturers
As global demand rises for monoclonal antibodies and other biopharmaceuticals, which is expected to grow by 5–10% per year, the Planova™ FG1 is poised to play a critical role in meeting these needs. The filter is designed for seamless compatibility with standard cleaning-in-place (CIP) and sterilization-in-place (SIP) procedures, facilitating its integration into existing biomanufacturing setups.
Future Developments and Product Line Expansion
Following the anticipated start of mass production in the coming months, Asahi Kasei Medical plans to broaden the Planova™ FG1 line with additional filters boasting larger surface areas. This strategic move aims to assist customers in scaling their processes efficiently, reinforcing Asahi Kasei Medical's standing among biopharmaceutical manufacturers.
A Message from Leadership
“Asahi Kasei Medical is excited to unveil the Planova™ FG1 next-generation virus removal filter,” stated Ken Shinomiya, President of Asahi Kasei Medical. “Our aim is to continue supporting biopharmaceutical manufacturers with our diverse and expanding product offerings, ensuring the safe and efficient production of medicines that patients depend on.”
About Asahi Kasei
The Asahi Kasei Group has been a pivotal contributor to improving quality of life globally. Established in 1922, the company has diversified successfully over the decades, adapting to the changing needs of society. With over 49,000 employees globally, Asahi Kasei remains committed to providing solutions that address pressing global challenges through its three main sectors: Material, Homes, and Health Care.
Sustainability and Future Goals
In alignment with global commitments to sustainability, Asahi Kasei is striving towards achieving carbon neutrality by 2050. The company's ongoing initiatives and innovative solutions reflect a deep commitment to fostering a sustainable future.
Frequently Asked Questions
What is the main purpose of the Planova FG1 filter?
The Planova FG1 filter is designed for effective virus removal during the manufacturing of biotherapeutics, enhancing production efficiency.
How does the Planova FG1 improve upon previous models?
It offers a higher filtration speed, which is approximately seven times faster than the earlier model, Planova BioEX, and reduces the risk of virus breakthrough.
Who will benefit from the Planova FG1 filter?
Biopharmaceutical manufacturers looking to enhance their production processes and maintain viral safety standards will greatly benefit from this filter.
What are the environmental commitments of Asahi Kasei?
Asahi Kasei is dedicated to sustainability efforts, aiming for carbon neutrality by 2050 while continually providing innovative solutions to global challenges.
When will the Planova FG1 be available?
Mass production of the Planova FG1 filter is set to begin imminently, with a range of new filter products planned for release shortly afterwards.
